Publication | Closed Access

Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation

Neurodegenerative Diseasesβ-Amyloid ProteinDiabetic Metabolic DisorderMedicineDiabetesNf-κb Pathway ActivationNeuropharmacologyNeurochemical BiomarkersDiabetes ComplicationsNeurosciencePharmacologyInsulin Signaling